Drug-eluting stents for treatment of focal infrapopliteal lesions;Medikamenten-beschichtete Stents zur Behandlung fokaler Läsionen der Unterschenkelarterien

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 2, 2012, Pages 90-95

  Rastan, Aljoscha ^a   Noory, Elias ^a   Zeller, Thomas ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Angioplasty; Drugeluting stent; Infra popliteal arteries; Peripheral artery disease

Indexed keywords

RAPAMYCIN;

BARE METAL STENT; COCHRANE LIBRARY; CRITICAL LIMB ISCHEMIA; DRUG ELUTING STENT; EMBASE; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; LIMB SALVAGE; MEDLINE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVASCULARIZATION; REVIEW; TREATMENT DURATION; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; LIMB SALVAGE; PATIENT SELECTION; POPLITEAL ARTERY; PROSTHESIS DESIGN; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84858602154     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000170     Document Type: Review

References (26)

1. Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, Kahn V. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg [Torino]. 2010; 51: 183-91.
2. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo A, Rand T, Sheiban I. Infragenicular stent implantation for below-the knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009; 16: 251-60.
3. Bosiers M, Deloose K, Callaert J, Keire K, Verbist J, Peeters P. Drugeluting stents below the knee. J Cardiovasc Surg [Torino]. 2011; 52: 231-4.
4. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter ardiovasc Interv. 2006; 68: 93-8
5. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery ndoluminal interventions for restpain and tissue loss. J Vasc Surg. 2008; 48: 619-25; Discussion 25-6.
6. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Percutaneous superficial femoral artery interventions for claudication-does runoff matter? Ann Vasc Surg. 2008; 22: 790-8.
7. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudica- tion: early and one-year outcomes. J Am Coll Cardiol. 2004; 44: 2307-14.
8. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below the-knee drug-eluting stents: the PaRADISE trial. J Am Coll Cardiol. 2010; 55: 1580-9.
9. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease [lower extremity, renal, mesenteric, and abdominal aortic]: executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines [Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease] endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006; 47: 1239-312.
10. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, Siablis D. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011; 18: 1-12.
11. Krankenberg H, Sorge I, Zeller T, Tubler T. Percutaneous translumi- nal angioplasty of infrapopliteal ar- teries in patients with intermittent claudication: acute and one-year results. Catheter Cardiovasc Interv. 2005; 64: 12-7.
12. Martens JM, Knippenberg B, Vos JA, de Vries JP, Hansen BE, van Overhagen H. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Vasc Surg. 2009; 3: 687-9
13. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989; 3: 273-7.
14. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease [TASC II]. J Vasc Surg. 2007; 45 Suppl S: S5-67.
15. Peregrin JH, Koznar B, Kovac J, Lastovickova J, Novotny J, Vedlich D, Skibova J. PTA of infrapopliteal arteries: long term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010; 33: 720-5.
16. Rastan A, Schwarzwälder U, Noory E, Haj Taieb F, Beschorner U, Sixt S, Bürgelin KH, Amantea P, Neumann FJ, Zeller T. Primary Use of Sirolimus-eluting Stents for Angioplasty of Infrapopliteal Arteries. J Endovasc Ther. 2010; 17: 480-7.
17. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E, Sixt S, Schwarz T, Brechtel K, Böhme C, Neumann FJ, Zeller T. Sirolimus-eluting Stents versus Bare-Metal Stents for treatment of focal lesions in infrapopliteal arteries: A double blind, multi-centre randomized clinical trial. Eur Heart J. 2011; 32: 2274-81.
18. Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with criticallimb ischemia: long-term follow-up. Catheter Cardiovasc Interv. 2008; 72: 112-5.
19. Salapura V, Blinc A, Kozak M, Jezovnik MK, Pohar Perme M, Berden P, Kuhelj D, Kljucevsek T, Popovic P, Stankovic M, Vrtovec M, Surlan M. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty. VASA. 2010; 39: 159-68.
20. Scheinert D, Ulrich M, Scheinert S, Sax J, Bräunlich S, Biamino G. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006; 2: 169-74.
21. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse H-J, Varcoe R, Scheinert D. First ex-perience with drug-eluting Balloons in infrapopliteal Arteries. J Am Coll Cardiol. 2011; 58: 1105-9.
22. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A, Tsolakis J. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal an- gioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther. 2007; 14: 241-50.
23. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Christeas N, Kagadis GC. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc interv Radiol. 2007; 18: 1351-61.
24. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis Gc, Tsolakis J. Infrapop liteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of longterm angiographic and clinical out- come. J Vasc Interv Radiol. 2009; 9: 1141-50.
25. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE, Taylor LM. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996; 94: 3026-49.
26. Zeller T, Sixt S, Rastan A. New techniques for endovascular treatment of peripheral artery disease with fo cus on chronic limb ischemia. Vasa. 2009; 38: 3-12.